The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Luderer Albert | Interim Chief Executive, Director | Buy(P) | 4K | $1.21 | $5K |
| Aug 21, 2026 | Luderer Albert | Interim Chief Executive, Director | Buy(P) | 4K | $1.22 | $5K |
| Aug 3, 2026 | Dixon Jonathan V. | General Counsel | Grant(A) | 15K | — | $0 |
| Aug 3, 2026 | Oldakowski Mark | Chief Operating Officer | Grant(A) | 15K | — | $0 |
| Aug 3, 2026 | Adamchak Mark | Principal Accounting Officer | Grant(A) | 5K | — | $0 |
| Aug 3, 2026 | Hastie Alex Reid | Chief Scientific Officer | Grant(A) | 54K | — | $0 |
| Jun 3, 2026 | Dixon Jonathan V. | GENERAL COUNSEL | Tax withholding(F) | 24 | $1.30 | $31 |
| Jun 3, 2026 | Oldakowski Mark | CHIEF OPERATING OFFICER | Tax withholding(F) | 27 | $1.30 | $35 |
| Jun 3, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | Tax withholding(F) | 24 | $1.30 | $31 |
| Jun 3, 2026 | Adamchak Mark | Principal Accounting Officer | Tax withholding(F) | 7 | $1.30 | $9 |
| May 14, 2026 | Barker David L | Director | Grant(A) | 9K | — | $0 |
| May 14, 2026 | Vuori Kristiina MD | Director | Grant(A) | 9K | — | $0 |
| May 14, 2026 | Twomey Christopher J | Director | Grant(A) | 9K | — | $0 |
| May 14, 2026 | Linney Yvonne | Director | Grant(A) | 9K | — | $0 |
| May 14, 2026 | Rajkovic Aleksandar | Director | Grant(A) | 9K | — | $0 |
| Feb 17, 2026 | Holmlin R. Erik | PRESIDENT AND CEO, Director | Tax withholding(F) | 51 | $1.10 | $56 |
| Feb 17, 2026 | Oldakowski Mark | CHIEF OPERATING OFFICER | Tax withholding(F) | 20 | $1.10 | $22 |
| Feb 17, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | Tax withholding(F) | 18 | $1.10 | $20 |
| Feb 17, 2026 | Dixon Jonathan V. | GENERAL COUNSEL | Tax withholding(F) | 6 | $1.10 | $7 |
| Feb 17, 2026 | Adamchak Mark | Principal Accounting Officer | Tax withholding(F) | 3 | $1.10 | $3 |
| Feb 2, 2026 | Holmlin R. Erik | PRESIDENT AND CEO, Director | Grant(A) | 69K | — | $0 |
| Feb 2, 2026 | Oldakowski Mark | CHIEF OPERATING OFFICER | Grant(A) | 28K | — | $0 |
| Feb 2, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | Grant(A) | 28K | — | $0 |
| Feb 2, 2026 | Dixon Jonathan V. | GENERAL COUNSEL | Grant(A) | 26K | — | $0 |
| Feb 2, 2026 | Adamchak Mark | Principal Accounting Officer | Grant(A) | 11K | — | $0 |
| Sep 11, 2025 | Oldakowski Mark | Chief Operating Officer | Tax withholding(F) | 59 | $4.06 | $240 |
| Sep 11, 2025 | Chaubey Alka | Chief Medical Officer | Tax withholding(F) | 51 | $4.06 | $207 |
| Jun 11, 2025 | Rajkovic Aleksandar | Director | Grant(A) | 3K | — | $0 |
| Jun 11, 2025 | Mamuszka Hannah | Director | Grant(A) | 3K | — | $0 |
| Jun 11, 2025 | Barker David L | Director | Grant(A) | 3K | — | $0 |
| Jun 11, 2025 | Luderer Albert | Director | Grant(A) | 3K | — | $0 |
| Jun 11, 2025 | Linney Yvonne | Director | Grant(A) | 3K | — | $0 |
| Jun 11, 2025 | Vuori Kristiina MD | Director | Grant(A) | 3K | — | $0 |
| Jun 11, 2025 | Twomey Christopher J | Director | Grant(A) | 3K | — | $0 |
| Jun 3, 2025 | Dixon Jonathan V. | General Counsel | Tax withholding(F) | 25 | $3.69 | $92 |
| Jun 3, 2025 | Holmlin R. Erik | President and CEO, Director | Tax withholding(F) | 75 | $3.69 | $277 |
| Jun 3, 2025 | Chaubey Alka | Chief Medical Officer | Tax withholding(F) | 24 | $3.69 | $89 |
| Jun 3, 2025 | Adamchak Mark | Principal Accounting Officer | Tax withholding(F) | 7 | $3.69 | $26 |
| Jun 3, 2025 | Oldakowski Mark | Chief Operating Officer | Tax withholding(F) | 27 | $3.69 | $100 |
| Mar 14, 2025 | Chaubey Alka | Chief Medical Officer | Grant(A) | 7K | — | $0 |
| Mar 14, 2025 | Oldakowski Mark | Chief Operating Officer | Grant(A) | 7K | — | $0 |
| Mar 14, 2025 | Holmlin R. Erik | President and CEO, Director | Tax withholding(F) | 198 | $3.47 | $687 |
| Mar 14, 2025 | Holmlin R. Erik | President and CEO, Director | Grant(A) | 17K | — | $0 |
| Mar 14, 2025 | Adamchak Mark | Principal Accounting Officer | Grant(A) | 3K | — | $0 |
| Mar 14, 2025 | Dixon Jonathan V. | General Counsel | Grant(A) | 7K | — | $0 |
| Feb 15, 2025 | Adamchak Mark | Principal Accounting Officer | Tax withholding(F) | 4 | $5.73 | $23 |
| Feb 15, 2025 | Chaubey Alka | Chief Medical Officer | Tax withholding(F) | 18 | $5.73 | $103 |
| Feb 15, 2025 | Holmlin R. Erik | President and CEO, Director | Tax withholding(F) | 51 | $5.73 | $292 |
| Feb 15, 2025 | Dixon Jonathan V. | General Counsel | Tax withholding(F) | 6 | $5.73 | $34 |
| Feb 15, 2025 | Oldakowski Mark | Chief Operating Officer | Tax withholding(F) | 20 | $5.73 | $115 |
| Oct 1, 2024 | Adamchak Mark | Principal Accounting Officer | Grant(A) | 18K | — | $0 |
| Sep 11, 2024 | Chaubey Alka | Chief Medical Officer | Tax withholding(F) | 3K | $0.48 | $1K |
| Sep 11, 2024 | Oldakowski Mark | Chief Operating Officer | Tax withholding(F) | 4K | $0.48 | $2K |
| Jun 18, 2024 | Linney Yvonne | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2024 | Twomey Christopher J | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2024 | Mamuszka Hannah | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2024 | Wong Vincent Jung-Fai | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2024 | Barker David L | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2024 | Vuori Kristiina MD | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2024 | Luderer Albert | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2024 | Rajkovic Aleksandar | Director | Grant(A) | 30K | — | $0 |
| Jun 3, 2024 | Chaubey Alka | CHIEF MEDICAL OFFICER | Grant(A) | 16K | — | $0 |
| Jun 3, 2024 | Chaubey Alka | CHIEF MEDICAL OFFICER | Grant(A) | 75K | — | $0 |
| Jun 3, 2024 | Dixon Jonathan V. | GENERAL COUNSEL | Grant(A) | 15K | — | $0 |
| Jun 3, 2024 | Dixon Jonathan V. | GENERAL COUNSEL | Grant(A) | 68K | — | $0 |
| Jun 3, 2024 | Holmlin R. Erik | PRESIDENT AND CEO, Director | Grant(A) | 44K | — | $0 |
| Jun 3, 2024 | Holmlin R. Erik | PRESIDENT AND CEO, Director | Grant(A) | 204K | — | $0 |
| Jun 3, 2024 | Kama Gulsen | Chief Financial Officer | Grant(A) | 16K | — | $0 |
| Jun 3, 2024 | Kama Gulsen | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| Jun 3, 2024 | Oldakowski Mark | CHIEF OPERATING OFFICER | Grant(A) | 16K | — | $0 |
| Jun 3, 2024 | Oldakowski Mark | CHIEF OPERATING OFFICER | Grant(A) | 75K | — | $0 |
| Feb 15, 2024 | Dixon Jonathan V. | GENERAL COUNSEL | Tax withholding(F) | 402 | $1.27 | $511 |
| Feb 15, 2024 | Holmlin R. Erik | PRESIDENT AND CEO, Director | Tax withholding(F) | 3K | $1.27 | $4K |
| Feb 15, 2024 | Oldakowski Mark | CHIEF OPERATING OFFICER | Tax withholding(F) | 1K | $1.27 | $2K |
| Feb 15, 2024 | Chaubey Alka | CHIEF MEDICAL OFFICER | Tax withholding(F) | 1K | $1.27 | $1K |
| Sep 18, 2023 | Kama Gulsen | Chief Financial Officer | Grant(A) | 106K | — | $0 |
| Sep 18, 2023 | Chaubey Alka | Chief Medical Officer | Grant(A) | 20K | — | $0 |
| Sep 18, 2023 | Chaubey Alka | Chief Medical Officer | Grant(A) | 40K | — | $0 |
| Sep 18, 2023 | Oldakowski Mark | Chief Operating Officer | Grant(A) | 20K | — | $0 |
| Sep 18, 2023 | Oldakowski Mark | Chief Operating Officer | Grant(A) | 40K | — | $0 |
| Jun 14, 2023 | Barker David L | Director | Grant(A) | 250K | — | $0 |
| Jun 14, 2023 | Twomey Christopher J | Director | Grant(A) | 250K | — | $0 |
| Jun 14, 2023 | Vuori Kristiina MD | Director | Grant(A) | 250K | — | $0 |
| Jun 14, 2023 | Wong Vincent Jung-Fai | Director | Grant(A) | 250K | — | $0 |
| Jun 14, 2023 | Linney Yvonne | Director | Grant(A) | 250K | — | $0 |
| Jun 14, 2023 | Luderer Albert | Director | Grant(A) | 250K | — | $0 |
| Jun 14, 2023 | Rajkovic Aleksandar | Director | Grant(A) | 250K | — | $0 |
| Jun 14, 2023 | Mamuszka Hannah | Director | Grant(A) | 250K | — | $0 |
| Jun 13, 2023 | Mamuszka Hannah | Director | Buy(P) | 66K | $0.76 | $50K |
| May 16, 2023 | Holmlin R. Erik | President and CEO, Director | Buy(P) | 15K | $0.64 | $10K |
| May 12, 2023 | Holmlin R. Erik | President and CEO, Director | Tax withholding(F) | 50K | $0.66 | $33K |
| May 12, 2023 | Oldakowski Mark | Chief Operating Officer | Tax withholding(F) | 41K | $0.66 | $27K |
| May 12, 2023 | Stewart Christopher P. | Chief Financial Officer | Buy(P) | 50K | $0.67 | $34K |
| Feb 15, 2023 | Stewart Christopher P. | Chief Financial Officer | Grant(A) | 105K | — | $0 |
| Feb 15, 2023 | Stewart Christopher P. | Chief Financial Officer | Grant(A) | 490K | — | $0 |
| Feb 15, 2023 | Chaubey Alka | Chief Medical Officer | Grant(A) | 120K | — | $0 |
| Feb 15, 2023 | Chaubey Alka | Chief Medical Officer | Grant(A) | 560K | — | $0 |
| Feb 15, 2023 | Oldakowski Mark | Chief Operating Officer | Grant(A) | 120K | — | $0 |
| Feb 15, 2023 | Oldakowski Mark | Chief Operating Officer | Grant(A) | 560K | — | $0 |
| Feb 15, 2023 | Holmlin R. Erik | President and CEO, Director | Grant(A) | 300K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Bionano Genomics, Inc., SEC CIK 0001411690. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under BNGO and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for BNGO